Researchers Create Yeast Consortium for Efficient Lignan Biosynthesis

Lignans are low molecular weight polyphenolic compounds with important antitumor and antiviral properties. However, their low amounts in medicinal plants and complex structures make sustainable production through plant extraction and chemical synthesis challenging, limiting their availability to meet market demand.

In a study published in Nature Chemical Biology, a research group led by Prof. Zhou Yongjin from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences, collaborating with Prof. Zhang Lei and Prof. Chen Wansheng from the Naval Medical University, has achieved the biosynthesis of the antiviral ingredient lignan glycoside in yeast Saccharomyces cerevisiae.

Researchers constructed a synthetic yeast consortium inspired by plant metabolism. By mimicking the spatial and temporal regulation of plant biosynthesis, they designed a system with obligated mutualism, enabling metabolic division of labor among different yeast strains. 

This approach effectively reduced side reactions caused by the broad substrate spectrum of 4-coumarate: CoA ligase and improved the efficiency of metabolic flux toward the target product. Based on this innovative strategy, researchers addressed challenges related to side reactions and metabolic network promiscuity.

Besides, researchers designed two auxotrophic yeast strains (met15Δ and ade2Δ) to form a mutualistic relationship, cross-feeding metabolites while dividing the biosynthetic pathway into upstream and downstream. This enabled the de novo synthesis of lariciresinol diglucoside through over 40 enzymatic reactions.

Our work demonstrates that Saccharomyces cerevisiae auxotrophic strains spontaneously establish a mutualistic community for the heterologous synthesis of complex active ingredients in traditional Chinese medicine. And this strategy is expected to be extended to the design of other stable cooperative yeast cell systems to accomplish complex bioengineering tasks." 

Prof. Zhou Yongjin, Dalian Institute of Chemical Physics, Chinese Academy of Sciences

Source:
Journal reference:

Chen, R., et al. (2025). De novo biosynthesis of plant lignans by synthetic yeast consortia. Nature Chemical Biology. doi.org/10.1038/s41589-025-01861-z.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New computational strategy enables design of drug-induced protein interactions